Specialties:

Most Popular Reports:

Newest Reports:

Discussion Alcohol Dependence-Impact of Vivitrol Launch_AUG2006
July 2006

Deliverable: Transcripts

Objectives:

  • Understand current alcohol dependence treatment landscape, including the current use of Vivitrol™ (naltrexone for extended-release injectable suspension)
  • Understand facilitators and barriers to use
  • Estimate trends in use of Vivitrol and rationale behind expectations
  • Elicit opinions on efficacy and adequacy of Cephalon educational and promotional activities

Products Highlighted:

  • Vivitrol, Cephalon/Alkermes
  • Campral® (acamprosate calcium), Merck Santé/Forest Laboratories
  • Oral naltrexone
Topics:

  • Current treatment practices for alcohol dependence
  • Unmet needs in treating alcohol dependence
  • Awareness of Vivitrol
  • Facilitators and barriers to Vivitrol use
  • Estimated uptake of Vivitrol
  • Potential of off-label Vivitrol use

Quotes:

  • “Although acamprosate has grown the market for alcoholism medications over that for naltrexone and disulfiram, the major problem is…”
  • “First line choice of medication is…”
  • “The strength of acamprosate, in my opinion, is…”
  • “The obvious niche for Vivitrol that I see for off-label use would be…”
  • “In six months I expect to have a minimum of xx patients on Vivatrol. Vivatrol xx% Campral xx% Antabuse xx%”

Screening Criteria:

  • Psychiatry, Addiction Medicine or Addiction Psychiatry – board certified
  • n=8-10
  • In practice between 3-35 years
  • At least 50% of professional time treating patients (versus research)
  • Affiliated with high-volume treatment center with an academic affiliation
  • Personally see at least 20 alcohol- OR opiate-dependent patients per month
  • At least 25% of substance abuse patients alcohol dependent
  • Some panelists experienced using Vivitrol, either after its approval (6/13) or in clinical trials
  • Not an alcohol dependence market research participant in past 3 months

Representative Institutions:

  • Holyoke Hospital
  • Mount Sinai
  • Northtown Clinic & Mercy Hospital
  • New York University Medical Center
  • Pine Grove Behavioral Health
  • St. Luke's Roosevelt Hospital Center
  • University of North Carolina at Chapel Hill
  • Kona Community Hospital
  • The William J. Farley Center
Download this report

 

 

> about us      > contact us
© Panel Intelligence, LLC. 1999-2008. All rights reserved.
A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR)
Privacy Policy